NYSE: RMD
Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kaushik GhoshalChief Commercial Officer SaaS2025-03-109,745$239.31
$2.33MSell
Kaushik GhoshalChief Commercial Officer SaaS2025-03-103,589$146.34
$525.21kBuy
Brett SandercockChief Financial Officer2025-03-101,000$230.36
$230.36kSell
Kaushik GhoshalChief Commercial Officer SaaS2025-03-10169$146.34
$24.73kBuy
Kaushik GhoshalChief Commercial Officer SaaS2025-03-10105$211.76
$22.23kBuy
Kaushik GhoshalChief Commercial Officer SaaS2025-03-105,882$211.76
$1.25MBuy
Michael J. FarrellChief Executive Officer2025-03-078,009$229.20
$1.84MSell
Michael J. FarrellChief Executive Officer2025-03-078,009$101.64
$814.03kBuy
Peter C. FarrellDirector2025-03-052,000$227.71
$455.42kSell
Michael J. RiderGlobal General Counsel2025-03-0364$234.10
$14.98kSell

1 of 9

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc12.37%18,173,462$4.05BInstitution
Blackrock Inc8.59%12,611,533$2.81BInstitution
State Street Corp4.40%6,466,976$1.44BInstitution
Bank Of New York Mellon Corp3.70%5,431,906$1.21BInstitution
Geode Capital Management LLC2.69%3,944,084$879.18MInstitution
Morgan Stanley2.64%3,875,371$863.86MInstitution
Invesco Ltd1.58%2,325,009$518.27MInstitution
Northern Trust Corp1.16%1,702,590$379.52MInstitution
Christopher G. Roberts1.16%1,700,337$379.02MInsider
Michael A. 1. Quinn0.87%1,277,650$284.80MInsider

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD61.30%4.24%Net SellingNet Selling
ALC53.06%0.00%
BAX85.44%14.56%Net SellingNet Selling
COO98.07%1.04%Net SellingNet Selling
WST96.28%3.72%Net BuyingNet Buying

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 61.30% institutional shareholders, 4.24% Resmed insiders, and 34.46% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.16% of the company. Christopher G. Roberts's Resmed shares are currently valued at $376.27M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.